Ascendis Pharma A/S - Ordinary Share (NQ:ASND)
264.16
+2.58
(+0.99%)
Streaming Delayed Price
Updated: 11:43 AM EDT, Jun 26, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Ascendis (ASND) Q1 2026 Earnings Call Transcript ↗
May 08, 2026
Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗
February 23, 2026
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
A Look Ahead: Ascendis Pharma's Earnings Forecast ↗
November 11, 2025
Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗
February 11, 2026
Why Dyne Therapeutics Stock Was Crushing it This Week ↗
November 21, 2025
Ascendis (ASND) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Looking Into Ascendis Pharma AS's Recent Short Interest ↗
October 21, 2025
What Does the Market Think About Ascendis Pharma AS? ↗
September 29, 2025
Frequently Asked QuestionsIs Ascendis Pharma A/S - Ordinary Share publicly traded?
Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.
What exchange does Ascendis Pharma A/S - Ordinary Share trade on?
Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?
The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market
What is the current price of Ascendis Pharma A/S - Ordinary Share?
The current price of Ascendis Pharma A/S - Ordinary Share is 264.16
When was Ascendis Pharma A/S - Ordinary Share last traded?
The last trade of Ascendis Pharma A/S - Ordinary Share was at 06/26/26 11:43 AM ET
What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?
The market capitalization of Ascendis Pharma A/S - Ordinary Share is 15.10B
How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?
Ascendis Pharma A/S - Ordinary Share has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
